Dysbiosis of intestinal microbiota in early life aggravates high-fat diet induced dysmetabolism in adult mice
Shiara Ortiz-Pujols, director of Obesity Medicine at Northwell Staten Island University Hospital, told The Post
Key areas requiring investigation include bioavailability enhancement strategies, therapeutic window identification, and patient stratification based on genetic and environmental factors
Oral GLP1 therapy for type 2 diabetes eliminates that barrier, creating new pathways for earlier intervention and broader use
References: NHS How to lose weight safely
What GLP-1s Actually Do to Your Body Medications like semaglutide and tirzepatide work by slowing down your digestive system, reducing your appetite, and improving insulin sensitivity